Jennifer Effie Amengual, MD, discussed using epigenetic drugs to enhance immune surveillance and other novel lymphoma therapeutic strategies.
Yale Cancer Center | Strategic Alliance Partners
Latest from Yale Cancer Center
Advertisement
Advertisement
Trending on CancerNetwork
1
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
2
FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer
3
Data Readouts to Watch at the 2026 ASCO Annual Meeting
4
Sacituzumab Tirumotecan Meets PFS End Point as 1L Option in Advanced TNBC
5